The receptor tyrosine kinase Mer promotes multiple myeloma progression and osteolytic bone disease

被引：0

作者：

Engelmann, J. ^{[1
,2
]}

Ben Batalla, I. ^{[1
,2
]}

Taipaleenmaeki, H. ^{[3
]}

Riecken, K. ^{[4
]}

Gensch, V. ^{[1
,2
]}

Paesler, S. ^{[1
,2
]}

Berenbrok, N. ^{[1
,2
]}

Vargas, M. E. ^{[1
,2
]}

Waizenegger, J. ^{[2
]}

Fehse, B. ^{[4
]}

Pantel, K. ^{[2
]}

Darwish, I. ^{[5
]}

Bhamidipati, S. ^{[5
]}

Masuda, E. ^{[5
]}

Bokemeyer, C. ^{[1
]}

Hesse, E. ^{[3
]}

Loges, S. ^{[1
,2
]}

机构：

[1] Univ Klinikum Hamburg Eppendorf, Med Klin & Poliklin 2, Abt Pneumol, Onkol,Hamatol,Knochenmarktransplantat, Hamburg, Germany

[2] Univ Klinikum Hamburg Eppendorf, Inst Tumorbiol, Hamburg, Germany

[3] Univ Klinikum Hamburg Eppendorf, Expt Unfallchirurg, Heisenberg Arbeitsgrp, Hamburg, Germany

[4] Univ Klinikum Hamburg Eppendorf, Interdisziplinare Klin & Poliklin Stammzelltransp, Hamburg, Germany

[5] Rigel Pharmaceut Inc, San Francisco, CA USA

来源：

ONCOLOGY RESEARCH AND TREATMENT | 2019年 / 42卷

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

P708

引用

页码：190 / 190

页数：1

共 50 条

[31] Expression of receptor activator of nuclear factor κB ligand on bone marrow plasma cells correlates with osteolytic bone disease in patients with multiple myeloma
Heider, U
Langelotz, C
Jakob, C
Zavrski, I
Fleissner, C
Eucker, J
Possinger, K
Hofbauer, LC
Sezer, O
CLINICAL CANCER RESEARCH, 2003, 9 (04) : 1436 - 1440
[32] ROLE OF THE RECEPTOR TYROSINE KINASE MER IN THE DEVELOPMENT OF FIBROSIS IN NAFLD
Di Maira, G.
Petta, S.
Cappon, A.
Vivoli, E.
Valenti, L.
Dongiovanni, P.
Bugianesi, E.
Di Marco, V.
Marra, F.
DIGESTIVE AND LIVER DISEASE, 2015, 47 : E225 - E225
[33] Mer receptor tyrosine kinase signaling participates in platelet function
Chen, CL
Li, Q
Darrow, AL
Wang, YP
Derian, CK
Yang, J
de Garavilla, L
Andrade-Gordon, P
Damiano, BP
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2004, 24 (06) : 1118 - 1123
[34] Role of the receptor tyrosine kinase Mer in the development of fibrosis in NAFLD
Di Maira, Giovanni
Petta, Salvatore
Cappon, Andrea
Vivoli, Elisa
Valenti, Luca
Dongiovanni, Paola
Bugianesi, Elisabetta
Di Marco, Vito
Marra, Fabio
HEPATOLOGY, 2015, 62 : 687A - 687A
[35] CST6 suppresses osteolytic bone disease in multiple myeloma by blocking osteoclast differentiation
Gai, Dongzheng
Chen, Jin-Ran
Stewart, James P.
Nookaew, Intawat
Habelhah, Hasem
Ashby, Cody
Sun, Fumou
Cheng, Yan
Li, Can
Xu, Hongwei
Peng, Bailu
Garg, Tarun K.
Schinke, Carolina
Thanendrarajan, Sharmilan
Zangari, Maurizio
Chen, Fangping
Barlogie, Bart
van Rhee, Frits
Tricot, Guido
Shaughnessy, John D., Jr.
Zhan, Fenghuang
JOURNAL OF CLINICAL INVESTIGATION, 2022, 132 (18):
[36] Chemotherapy did not enhance the anti-osteolytic effects of bisphosphonate in multiple myeloma bone disease
Ogata, A
Kitano, M
Hashimoto, N
Iwasaki, T
Hamano, T
Kakishita, E
JOURNAL OF BONE AND MINERAL METABOLISM, 2002, 20 (04) : 240 - 242
[37] The Src Inhibitor AZD0530 Prevents the Development of Osteolytic Bone Disease in Multiple Myeloma
Heusschen, Roy
Muller, Josephine
Binsfeld, Marilene
Plougonven, Erwan
Mahli, Nadia
Carmeliet, Geert
Leonard, Angelique
Cohen-Solal, Martine
Vanderkerken, Karin
Beguin, Yves
Menu, Eline
Caers, Jo
BLOOD, 2015, 126 (23)
[38] Structural insights into the inhibited states of the Mer receptor tyrosine kinase
Huang, Xudong
Finerty, Patrick, Jr.
Walker, John R.
Butler-Cole, Christine
Vedadi, Masoud
Schapira, Matthieu
Parker, Sirlester A.
Turk, Benjamin E.
Thompson, Debra A.
Dhe-Paganon, Sirano
JOURNAL OF STRUCTURAL BIOLOGY, 2009, 165 (02) : 88 - 96
[39] Chemotherapy did not enhance the anti-osteolytic effects of bisphosphonate in multiple myeloma bone disease
Atsushi Ogata
Masayasu Kitano
Naoaki Hashimoto
Tsuyoshi Iwasaki
Teruaki Hamano
Eizo Kakishita
Journal of Bone and Mineral Metabolism, 2002, 20 : 240 - 242
[40] BRUTON TYROSINE KINASE EXPRESSION IN MULTIPLE MYELOMA
Elias, L.
Buggy, J.
HAEMATOLOGICA, 2013, 98 : 91 - 91

← 1 2 3 4 5 →